Making the Case for Structured Content: Smarter Labeling Approach for Pharma and MedTech

Structured content is no longer a future state; it is the present reality. It's a critical part of how leading organizations are transforming their global labeling operations. In this episode, featured speaker Joe Jenkins, VP of Business Development and Partnerships at Oberon, will unpack what structured content actually is, how it applies to various labeling documents (from package inserts and IFUs to SOPs and SmPCs), and why both Pharma and MedTech companies are moving toward this model.

Whether you're just beginning to explore structured content or struggling to move from theory to action, this discussion will offer practical guidance to help you start (or restart) your journey with clarity and confidence.

You'll also hear how some organizations are already saving hundreds of thousands of dollars annually by adopting structured content strategies that reduce translation costs, accelerate review cycles, and simplify global updates.

What You’ll Learn

• What structured content really means for labeling teams, and how it's different from your current approach
• How Pharma and MedTech companies are using structured content across labeling, patient information, SOPs, and more
• Key benefits, including cost savings, speed to market, and improved quality
• Practical starting points for structured content initiatives (even if you’re not ready for a full overhaul)
• Common pitfalls and lessons learned from early adopters

Who Should Attend

This session is designed for decision-makers and team leads in:

• Labeling and Packaging
• Regulatory Affairs
• Medical Writing and Technical Communications
• Quality and Compliance
• Global Labeling Operations
• Digital Transformation or Content Strategy roles within Pharma or MedTech

Speaker

• Joe Jenkins, Vice President of Business Development and Partnerships, Oberon